JT
ASMB icon

Jupiter Topco’s Assembly Biosciences ASMB Stock Holding History

Jupiter Topco’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4M Buy
+849,309
New +$23.1M 0.01% 616

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco's ASMB Position: Q2 2026 in Review

Jupiter Topco opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 849,309 shares worth $23.4M. The stake represents 0.01% of the portfolio and ranks #616 among its holdings.

85 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Jupiter Topco held 849,309 shares of Assembly Biosciences worth $23.4M as of Q2 2026.
  • Assembly Biosciences was a new Jupiter Topco position in Q2 2026.
  • Assembly Biosciences made up 0.01% of Jupiter Topco's portfolio in Q2 2026, its #616 holding.
  • 85 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.